At the forefront of biomedical innovation, our facilities combine next-generation equipment, advanced biomarker analysis platforms, and academic collaborations to accelerate translational research.
Our new laboratories in Cherrywood are dedicated to perform and progress the company ex-vivo biomarker and in-vitro cell cultures operations. Ulysses Neuroscience Ltd. new laboratories in Cherrywood are fully equipped for analysis of central and peripheral biomarkers related to neuroinflammation, synaptic plasticity and cytoskeleton integrity. The Ulysses team has now collected significant data and performed several studies that clearly underline the importance of these biomarkers in psychiatric and rare CNS diseases in bridging preclinical and clinical research. The cutting-edge cell culture facilities in Cherrywood represent a novel added force to Ulysses Neuroscience ltd. driving the implementation of our in-vitro cell culture platform.
